Exhibit 99.1
 NEWS RELEASE
 
 UROPLASTY REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER FY2011
 Global Sales increase 7%; U.S. Macroplastique product sales increase 69%
Gross Margin improves to 83%; Operating loss reduced by 33%
Company raises a net of $14.9 million from a public offering subsequent to quarter end Conference
call today at 3:30 p.m. CT
 MINNEAPOLIS, MN, August 10, 2010
  Fiscal First Quarter Results for the Period Ended June 30, 2010




---



##### 



Conference Call
  About Uroplasty, Inc.




---



##### 



Forward-Looking Information
  For Further Information:
 Uroplasty,
Inc.
David Kaysen, President and CEO, or
Medi Jiwani, Vice President, CFO, and Treasurer
952.426.6140
    
    EVC Group
Doug Sherk (Investors)
415.896.6820
Chris Gale (Media)
646.201.5431




---



##### 



Three Months EndedJune 30,2010
    
    
    2009Net sales
    
    $
    3,035,499
    
    
    $
    2,825,929Cost of goods sold
    
    
    510,696
    
    
    
    551,970Gross profit
    
    
    2,524,803
    
    
    
    2,273,959Operating expensesGeneral and administrative
    
    
    850,317
    
    
    
    848,551Research and development
    
    
    400,629
    
    
    
    527,815Selling and marketing
    
    
    1,988,526
    
    
    
    2,057,288Amortization
    
    
    210,768
    
    
    
    211,8133,450,240
    
    
    
    3,645,467Operating loss
    
    
    (925,437
    )
    
    
    (1,371,508
    )Other income (expense)Interest income
    
    
    13,628
    
    
    
    31,399Interest expense
    
    
    (1,947
    )
    
    
    (7,907
    )Foreign currency exchange gain (loss)
    
    
    1,790
    
    
    
    (7,330
    )Other, net
    
    
    (192
    )
    
    
    (2,183
    )13,279
    
    
    
    13,979Loss before income taxes
    
    
    (912,158
    )
    
    
    (1,357,529
    )Income tax expense
    
    
    17,150
    
    
    
    8,245Net loss
    
    $
    (929,308
    )
    
    $
    (1,365,774
    )Basic and diluted loss per common share
    
    $
    (0.06
    )
    
    $
    (0.09
    )Weighted average common shares
outstanding:Basic and diluted
    
    
    15,307,000
    
    
    
    14,937,771




---



##### 



June 30, 2010
    
    
    March 31, 2010AssetsCurrent assets:Cash and cash equivalents & short-term investments
    
    $
    7,308,781
    
    
    $
    5,811,269Accounts receivable, net
    
    
    1,218,573
    
    
    
    1,287,440Inventories
    
    
    448,589
    
    
    
    341,497Income tax receivable
    
    
    
    
    
    
    23,820Other
    
    
    333,389
    
    
    
    237,321Total current assets
    
    
    9,309,332
    
    
    
    7,701,347Property, plant, and equipment, net
    
    
    1,134,454
    
    
    
    1,230,771Intangible assets, net
    
    
    2,322,328
    
    
    
    2,533,095Deferred tax assets
    
    
    100,530
    
    
    
    108,530Total assets
    
    $
    12,866,644
    
    
    $
    11,573,743Liabilities and Shareholders EquityCurrent liabilities:Accounts payable
    
    $
    571,531
    
    
    $
    485,594Current portion  deferred rent
    
    
    35,000
    
    
    
    35,000Income tax payable
    
    
    14,963
    
    
    
    10,000Accrued liabilities:Compensation
    
    
    786,962
    
    
    
    903,057Other
    
    
    304,818
    
    
    
    212,028Total current liabilities
    
    
    1,713,274
    
    
    
    1,645,679Deferred rent  less current portion
    
    
    103,693
    
    
    
    112,500Accrued pension liability
    
    
    590,705
    
    
    
    601,037Total liabilities
    
    
    2,407,672
    
    
    
    2,359,216Total shareholders equity
    
    
    10,458,972
    
    
    
    9,214,527Total liabilities and shareholders equity
    
    $
    12,866,644
    
    
    $
    11,573,743




---



##### 



Three Months EndedJune 30,2010
    
    
    2009Cash flows from operating activities:Net loss
    
    $
    (929,308
    )
    
    $
    (1,365,774
    )Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization
    
    
    284,053
    
    
    
    284,040Loss on disposal of equipment
    
    
    192
    
    
    
    2,186Share-based consulting expense
    
    
    6,664
    
    
    
    Share-based compensation expense
    
    
    69,603
    
    
    
    172,649Deferred income taxes
    
    
    (2,147
    )
    
    
    (969
    )Deferred rent
    
    
    (8,750
    )
    
    
    (8,750
    )Changes in operating assets and liabilities:Accounts receivable
    
    
    18,935
    
    
    
    (54,213
    )Inventories
    
    
    (127,155
    )
    
    
    30,618Other current assets and income tax receivable
    
    
    (76,681
    )
    
    
    (106,949
    )Accounts payable
    
    
    90,699
    
    
    
    (87,783
    )Accrued liabilities
    
    
    (9,192
    )
    
    
    (414,828
    )Accrued pension liability, net and income tax payable
    
    
    39,837
    
    
    
    35,291Net cash used in operating activities
    
    
    (643,250
    )
    
    
    (1,514,482
    )Cash flows from investing activities:Proceeds from sale of short-term investments
    
    
    500,000
    
    
    
    Purchase of short-term investments
    
    
    (3,000,000
    )
    
    
    (1,000,000
    )Purchases of property, plant and equipment
    
    
    (40,519
    )
    
    
    (16,487
    )Net cash used in investing activities
    
    
    (2,540,519
    )
    
    
    (1,016,487
    )Cash flows from financing activities:Proceeds from warrant and option exercise
    
    
    2,211,250
    
    
    
    Net cash provided by financing activities
    
    
    2,211,250
    
    
    
    Effect of exchange rates on cash and cash equivalents
    
    
    (29,969
    )
    
    
    18,319Net decrease in cash and cash equivalents
    
    
    (1,002,488
    )
    
    
    (2,512,650
    )Cash and cash equivalents at beginning of period
    
    
    2,311,269
    
    
    
    3,276,299Cash and cash equivalents at end of period
    
    $
    1,308,781
    
    
    $
    763,649Supplemental disclosure of cash flow information:Cash received(paid) during the period for income taxes
    
    $
    8,034
    
    
    $
    (7,908
    )




---



##### 



Three Months EndedJune 30,2010
    
    
    2009Gross ProfitGAAP gross profit
    
    $
    2,524,803
    
    
    $
    2,273,959% of sales
    
    
    83
    %
    
    
    80
    %Share-based compensation
    
    
    4,484
    
    
    
    13,544Depreciation expense
    
    
    15,698
    
    
    
    14,150Non-GAAP gross profit
    
    
    2,544,985
    
    
    
    2,301,653Operating ExpensesGAAP operating expenses
    
    
    3,450,240
    
    
    
    3,645,467Share-based compensation
    
    
    71,783
    
    
    
    159,105Depreciation expense
    
    
    57,587
    
    
    
    58,077Amortization expense
    
    
    210,768
    
    
    
    211,813Non-GAAP operating expenses
    
    
    3,110,102
    
    
    
    3,216,472Operating LossGAAP operating loss
    
    
    (925,437
    )
    
    
    (1,371,508
    )Share-based compensation
    
    
    76,267
    
    
    
    172,649Depreciation expense
    
    
    73,285
    
    
    
    72,227Amortization expense
    
    
    210,768
    
    
    
    211,813Non-GAAP operating loss
    
    $
    (565,117
    )
    
    $
    (914,819
    )